Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer.
Yoon-Koo KangYung-Jue BangShunsuke KondoHyun Cheol ChungKei MuroIsabelle DussaultChristoph HelwigMotonobu OsadaToshihiko DoiPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
In this first evaluation in Asian patients with heavily pretreated advanced GC/GEJC, bintrafusp alfa demonstrated a manageable safety profile and clinical activity.